Sonnet BioTherapeutics Holdings, Inc.
SONN
$1.16
-$0.01-0.86%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.06M | 4.86M | 149.50K | 3.55M | 3.79M |
| Total Receivables | 778.20K | 666.80K | 762.10K | 519.60K | 378.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 420.70K | 1.20M | 1.21M | 1.05M | 1.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.26M | 6.73M | 2.12M | 5.13M | 5.22M |
|
|
|||||
| Total Current Assets | 3.26M | 6.73M | 2.12M | 5.13M | 5.22M |
| Net Property, Plant & Equipment | 99.70K | 121.70K | 143.90K | 165.50K | 186.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 478.60K | 335.10K | 509.10K | 503.50K | 499.80K |
| Total Assets | 3.84M | 7.18M | 2.77M | 5.80M | 5.91M |
|
|
|||||
| Total Accounts Payable | 1.75M | 1.64M | 2.18M | 1.88M | 1.75M |
| Total Accrued Expenses | 1.34M | 1.39M | 940.70K | 1.15M | 930.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 90.40K | 87.30K | 84.30K | 81.30K | 78.50K |
| Total Finance Division Other Current Liabilities | 1.70K | 1.70K | 1.80K | 2.60K | 3.30K |
| Total Other Current Liabilities | 1.70K | 1.70K | 1.80K | 2.60K | 3.30K |
| Total Current Liabilities | 3.17M | 3.12M | 3.21M | 3.11M | 2.76M |
|
|
|||||
| Total Current Liabilities | 3.17M | 3.12M | 3.21M | 3.11M | 2.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 23.60K | 46.60K | 68.80K | 90.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.17M | 3.15M | 3.26M | 3.18M | 2.86M |
|
|
|||||
| Common Stock & APIC | 125.00M | 124.88M | 117.20M | 117.17M | 114.10M |
| Retained Earnings | -124.33M | -120.84M | -117.68M | -114.55M | -111.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 662.30K | 4.04M | -485.70K | 2.62M | 3.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 662.30K | 4.04M | -485.70K | 2.62M | 3.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 662.30K | 4.04M | -485.70K | 2.62M | 3.05M |
|
|
|||||